303-45-7

Soild

antispermatogenic, antineoplastic, antiHIV

Gossypol is a mixture of natural polyphenols isolated from the cotton plant. It causes spermatogenesis arrest in humans and also functions as an anti-malarial agent. Antiinflammatory. Anticancer.

antispermatogenic, antineoplastic, antiHIV

Gossypol is a mixture of natural polyphenols isolated from the cotton plant. It causes spermatogenesis arrest in humans and also functions as an anti-malarial agent. Antiinflammatory. Anticancer.

Toxic by ingestion but is inactivated by heat, 0.04% max allowed in foods.

Lipophilic agent derived from cottonseed. Exhibits multiple biological effects including antifertility and anticancer activity. Pro-apoptotic; downregulates Bcl-2 and Bcl-XL.

Gossypol is mainly present in the roots, stems, leaves, and seeds of the plant cotton, and the highest content is found in cotton seeds. Its chemical structure was first determined by Adams in 1938 and was used to be studied in antitumor research.

Appearance: plate or needle-like crystals with yellow color, odorless, and tasteless. Solubility: do not dissolve in water, slightly soluble in ethanol, and soluble in chloroform, ether, acetone, ethyl acetate, dichloroethane, carbon tetrachloride, and pyridine. Difficult to dissolve in cyclohexane, benzene, and petroleum ether. Melting point: 184–214?°C.
Gossypol has a chiral structure with two optical isomers in the left and right. The formic acid gossypol or gossypol acetate was commonly used.

Gossypol is found in cotton and is made synthetically.

The close relationship between male infertility and the consumption of cottonseed products was first found in cotton-producing areas by Shandong scientists in 1971. Further study found that gossypol impaired the sperm quality significantly in rat, rabbit, and so on. Mechanism study showed that gossypol could interact with sperm and then trigger a cascade reaction for different stages of spermatogenesis. Acetate gossypol showed similar biological activities with gossypol. The clinical trial for gossypol tablet for the male contraceptive treatment was initiated in the 1973, which was produced in Shanghai, and the raw material was provided from Shanghai, Shandong, and Zhejiang province. During 1981–1985, the side effect, antifertility reversibility, and safety evaluation induced by gossypol were further investigated by the national 65-35-2-5 scientific group, which was carried out by prospective clinical study in 390 volunteers, and the results showed that there is no carcinogenic, teratogenic, and mutagenic effects in gossypol .

This product as gossypol acetate is recorded in the tenth volume of national standards for chemical drugs.
Solid formulations include compound acetate gossypol tablets and gossypol potassium chloride vitamin B capsule. Gossypol was used as male contraceptive drug in clinic previously but terminated due to the induced severer hypokalemia. Now, compound acetate gossypol tablets consisted of acetate gossypol and potassium chloride, vitamins are used for the treatment of uterine functional bleeding, uterine fibroids, and menorrhagia and endometriosis.

Gossypol is a male antifertility agent and PAF antagonist/inhibitor. Gossypol is a poisonous pigment found in cottonseed and its name is derived from the botanical name of the cotton plant, Gossypium.. Gossypium is extracted from selected hybrid species between two Gossypium species, Gossypium hirsutum and Gossypium barbadens. As a PAF antagonist/inhibitor, Gossypium markedly inhibited the contractile responses of guinea pig lung parenchyma strips stimulated with leukotriene B4, seukotriene D4, and PAF-acether.

There are significant differences in pharmacological effects of gossypol between male and female. In males, gossypol could significantly reduce sperm quality, as manifested by the reduced sperm density or activity. Mechanism study showed that gossypol could impair spermatogenic epithelium directly, and sperm cells and spermatocytes are the most sensitive. In female, gossypol could inhibit ovarian and endometrial, muscular steroid hormone receptor, hence thinning the endometrium and muscle layer and reducing menstrual flow ; therefore, gossypol acetate and potassium chloride, vitamins, and other combinations were prepared for the compound acetate gossypol tablets, which were used for the treatment of uterine functional bleeding, uterine fibroids, menorrhagia, and uterus endometriosis. The recommended daily oral dose is 20 mg. Gossypol dextrorate has no effect, with levorotate as the active ingredient; therefore, the role of L-gossypol is two times that of gossypol .
A good antitumor effect of gossypol and its derivatives was found in recent studies. Gossypol showed significant inhibition on cancer cell proliferation in vitro studies, including tumor cells derived from lymphatic and granulocytes, adrenal glands, breast, and cervical, rectal, and central nervous system. Studies have suggested that gossypol inhibits the catalytic activity of topoisomerase II and intervenes in the stability of topoisomerase – DNA complexes. Gossypol blocks the cell in S stage by reducing the activity of DNA polymerase alpha and beta and inhibiting DNA synthesis. Gossypol is a specific DNA synthesis inhibitor that inhibits cell division. In addition, gossypol can also exhibit antitumor effect by acting as a signal pathway regulator and inhibiting the energy metabolism of tumor cells .

Due to the presence of hypokalemia and irreversible antifertility risk of gossypol, the clinical indications of male contraceptives are not approved by the Chinese Food and Drug Administration. At present, gossypol and its derivatives are mainly used for female uterine fibroids, functional uterine bleeding, and endometriosis treatment. In addition, the treatment of gossypol and its derivatives in the tumor is gradually confirmed clinically, such as gossypol combined with docetaxel or cisplatin for the treatment of malignant non-small cell lung cancer, and is currently in phase III clinical trial . Gossypol combined with rituximab can achieve better therapeutic efficacy against granulocytic leukemia and is currently in phase II clinical trials .

in bovine granulosa cells, treatment with gossypol dose-dependently decreased hcg-induced camp formation. gossypol (12.5 μg/ml) inhibited basal camp level and progesterone secretion(2). gossypol (50 and 100 μg/ml) decreased the percentage of sperm that completed the swim-up procedure. when cultured with5 or 10 μg/ml gossypol, development of cleaved embryos was reduced(3). in the lymphocytes isolated from lymph nodes of balb/c mice, gossypol significantly inhibited the proliferation of mouse lymphocytes stimulated with phorbol ester plus ionomycin in a dose-dependent manner. gossypol significantly suppressed the lymphoblastic transformation of both t and b lymphocyte subsets. moreover, gossypol could induce apoptosis of lymphocytes in a time- and dose-dependent manner (4).

in male sprague-dawley rats, gossypol (25 mg/kg, i.p.) caused marked changes in the activity of the hepatic and serum γ-glutamyltransferase (ggt) and microsomal monooxygenases (5). rats that received lower gossypol doses (15 mg/kg/day for four weeks or 30 mg/kg/day for two weeks) showed morphological changes in the liver(6).

4°C, protect from light

[1]. gadelha i c n, fonseca n b s, oloris s c s, et al. gossypol toxicity from cottonseed products[j]. the scientific world journal, 2014, 2014.
[2]. lin y c, coskun s, sanbuissho a. effects of gossypol on in vitro bovine oocyte maturation and steroidogenesis in bovine granulosa cells[j]. theriogenology, 1994, 41(8): 1601-1611.
[3]. brocas c, rivera r m, paula-lopes f f, et al. deleterious actions of gossypol on bovine spermatozoa, oocytes, and embryos[j]. biology of reproduction, 1997, 57(4): 901-907.
[4]. xu w, xu l, lu h, et al. the immunosuppressive effect of gossypol in mice is mediated by inhibition of lymphocyte proliferation and by induction of cell apoptosis[j]. actapharmacologicasinica, 2009, 30(5): 597-604.
[5]. deoras d p, young-curtis p, dalvi r r, et al. effect of gossypol on hepatic and serum γ-glutamyltransferase activity in rats[j]. veterinary research communications, 1997, 21(5): 317-323.
[6]. ying w, hai-peng l. hepatotoxicity of gossypol in rats[j]. journal of ethnopharmacology, 1987, 20(1): 53-64.